Central fill pharmacy automation is a completely automated pharmacy dispensing system that reduces the need for manual or human labor by handling the entire inventory system with machines and robots.
The central fill pharmacy administers medications, validates, labels, and packages prescription products in a bag, and properly labels the bag so that they may be sorted and delivered to the other branches.
Global Central Fill Pharmacy Automation Market - Impact of the Coronavirus (COVID-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Dashboard by the World Health Organization, over 571.19 million cases and 6.38 million deaths due to coronavirus disease (COVID-19) were reported till July 28, 2022, across the globe.
Impact of COVID-19 on Demand and Supply of Central Fill Pharmacy Automation
The COVID-19 pandemic and lockdown in various countries across the globe have impacted the financial status of businesses across all sectors including private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; by directly affecting the production and demand of healthcare products; by creating disruptions in distribution channels; and by affecting the companies and various markets financially. Several countries such as Thailand, Indonesia, and Singapore are facing problems with regards to transportation and distribution of healthcare products.
According to the Swisslog Healthcare Ltd., 2020, a provider of integrated medication supply chain solutions to hospitals and health systems, central fill pharmacy automation can help overcome difficulties such as medication mistake, slow workflow, and others. Central fill pharmacy automation provides several benefits and features such as:
Therefore, the global central fill pharmacy automation market is expected to be positively impacted by COVID-19, owing to the benefits offered by the automated systems
The global central fill pharmacy automation market is estimated to be valued at US$ 416.06 Mn in 2022, and is expected to exhibit a CAGR of 12.2% over the forecast period (2022-2030).
Figure 1: Global Central Fill Pharmacy Automation Market Share (%) Analysis, By Product Type, 2022
Increasing need to reduce medication errors and develop automated systems with improved features is expected to drive growth of the global central fill pharmacy automation market over the forecast period.
For instance, according to the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP), 2019, medication errors in hospitals kills nearly 100 million people each year. It is critical to eliminate medication errors to improve healthcare facilities and services while ensuring patient safety. Using a pharmacy automation system to minimize errors connected to storage, medication, usage, and retrieval dispensing is critical.
Rising specialty drug dispensing demand from central fill pharmacies
The rising demand for specialty drug dispensing from central fill pharmacies is expected to drive the global central fill pharmacy automation market growth. Specialty medications have changed medicines in the last two decades, helping numerous patients with chronic conditions to improve their lifespan and quality of life. Any registered pharmacy can dispense a specialty drug as long as the product can be obtained from a manufacturer or via an authorized wholesale distribution channel. Due to increased investments from pharmaceutical stakeholders and greater efficiency, the global pharmaceutical sector has seen an increase in the supply of highly required generic drugs. This has ultimately assisted in driving the demand for central fill pharmacy automation across the globe.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2021 | Market Size in 2022: | US$ 416.06 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2030 |
| Forecast Period 2022 to 2030 CAGR: | 12.2% | 2030 Value Projection: | US$ 1,047.69 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Omnicell, ARxIUM, ScriptPro, Cardinal Health, Parata Systems, RxSafe, LLC, Tension Packaging & Automation, McKesson Corporation, Cornerstone Automation Systems, LLC, Quality Manufacturing Systems, Inc., Noritsu, Capsa Healthcare, Yuyama USA, and Catalyst Healthcare Ltd. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Global Central Fill Pharmacy Automation Market- Restraint
Lack of skilled professionals and high initial capital investments is expected to hamper the market growth. The capabilities of the pharma workforce have not yet aligned with emerging technologies such as automation, computer science, and process modelling, resulting in an increasing talent gap. As a result, firms are having difficulty finding these skills among the current workforce. Furthermore, due to additional tariffs, anti-dumping taxes, non-tariff obstacles, and stricter compliance, the cost of trade is rising. As a result, these logistical issues may slow the market growth during the projection period. Maintenance, power usage, service, technicians, and other costs are included in the entire budget. The high investment cost of central fill pharmacy automation systems has hindered the market expansion in low-income economies
Global Central Fill Pharmacy Automation Market – Regional Analysis
On the basis of region, the global central fill pharmacy automation market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to exhibit lucrative growth opportunities for the central fill pharmacy automation market, owing to increasing mergers and acquisition amongst market players. For instance, in July 2021, pharmacy automation provider, Parata Systems which is based in North Carolina, U.S, announced the acquisition of Synergy Medical, a privately held company that develops automation technologies to prepare and dispense solid oral medication in blister cards. This acquisition expanded Parata Systems offerings of innovative pharmacy automation technologies.
Moreover, Europe is expected to witness significant growth in the near future, owing to increasing strategies such as partnership amongst market players. For instance, in July 2019, RxSafe, LLC, announced partnership with U.K.-based Centred Solutions, Ltd to deliver adherence strip packaging automation to the European market. Under the agreement, Centred Solutions became the exclusive distributor of RapidPakRx in the U.K and the rest of the European Union (EU).
Figure 2: Global Central Fill Pharmacy Automation Market Value (US$ Mn), by Region, 2022
Global Central Fill Pharmacy Automation Market – Competitive Landscape
Major players operating in the global central fill pharmacy automation market include Omnicell, ARxIUM, ScriptPro, Cardinal Health, Parata Systems, RxSafe, LLC, Tension Packaging & Automation, McKesson Corporation, Cornerstone Automation Systems, LLC, Quality Manufacturing Systems, Inc., Noritsu, Capsa Healthcare, Yuyama USA, and Catalyst Healthcare Ltd.
Central fill pharmacy automation systems are computer-controlled devices that count, package, and fill massive numbers of prescriptions received electronically from connected branches that are centrally located on a continuous cycle.
A third-party partner providing central fill as a service involves filling and distributing prescription drugs for a small or medium retail pharmacy chain from a single site as opposed to from individual pharmacy locations. The vendor completes the dispensing processes up till the prescription is delivered to the pharmacy locations or directly to the patient after the prescription has been decided upon. The seven fundamental steps are labelling, dispensing, imaging, capping, confirming, packaging, and sorting/mailing.
Market Dynamics
Market players are involved in strategies such as facility expansions and thus, driving the market growth during the forecast period. For instance, in November, 2020, ARxIUM completed the expansion of UNC health pharmacy operations. The multi-year engagement that expands and integrates UNC health shared services center, UNC hospitals, and Rex hospitals. By implementing a range of automated, interoperable systems, the health systems has achieved advanced pharmacy safety and operation efficiency.
Market players are focused on product launches and approvals, which is expected to drive growth of the global central fill pharmacy automation market over the forecast period. For instance, in November 2018, ARxIUM, a leading pharmacy automation industry, launched a cGMP RIVA IV compounding system for 503B central-fill, hospital, and outsourcing pharmacies. It is the only fully automated cGMP system on the market.
Increasing partnerships by market players is expected to fuel growth of the global central fill pharmacy automation market. For instance, in July 2019, RxSafe, LLC, announced partnership with U.K.-based Centred Solutions, Ltd to deliver adherence strip packaging automation to the European market. Under the agreement, Centred Solutions became the exclusive distributor of RapidPakRx in the U.K and the rest of the European Union (EU).
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients